» Articles » PMID: 31439905

A Biomimetic 3D Model of Hypoxia-driven Cancer Progression

Overview
Journal Sci Rep
Specialty Science
Date 2019 Aug 24
PMID 31439905
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The fate of tumors depends both on the cancer cells' intrinsic characteristics and on the environmental conditions where the tumors reside and grow. Engineered in vitro models have led to significant advances in cancer research, allowing the investigation of cells in physiological environments and the study of disease mechanisms and processes with enhanced relevance. Here we present a biomimetic cancer model based on a collagen matrix synthesized through a biologically inspired process. We compared in this environment the responses of two breast tumor lineages characterized by different molecular patterns and opposite clinical behaviors: MCF-7 that belong to the luminal A subtype connected to an indolent course, and basal-like MDA-MB-231 connected to high-grade and aggressive disease. Cancer cells in the biomimetic matrix recreate a hypoxic environment that affects their growth dynamics and phenotypic features. Hypoxia induces apoptosis and the selection of aggressive cells that acquire expression signatures associated with glycolysis, angiogenesis, cell-matrix interaction, epithelial to mesenchymal transition and metastatic ability. In response to hypoxia MDA-MB-231 migrate on the collagen fibrils and undergo cellular senescence, while MCF-7 do not exhibit these behaviors. Our biomimetic model mimics the evolution of tumors with different grade of aggressiveness fostered by a hypoxic niche and provides a relevant technology to dissect the events involved in cancer progression.

Citing Articles

Functional biomaterials for biomimetic 3D in vitro tumor microenvironment modeling.

Ahmed T In Vitro Model. 2025; 2(1-2):1-23.

PMID: 39872875 PMC: 11756483. DOI: 10.1007/s44164-023-00043-2.


Modeling intratumor heterogeneity in breast cancer.

McDonough E, Barroso M, Ginty F, Corr D Biofabrication. 2024; 17(1.

PMID: 39642392 PMC: 11740194. DOI: 10.1088/1758-5090/ad9b50.


Oxygenating respiratoid biosystem for therapeutic cell transplantation.

Jang S, Yoo C, Kim H, Kim J, Lee D Nat Commun. 2024; 15(1):9151.

PMID: 39443443 PMC: 11500001. DOI: 10.1038/s41467-024-53246-w.


Reconstructed colorectal cancer model to dissect the anti-tumor effect of mesenchymal stromal cells derived extracellular vesicles.

DAngelo E, Tassinari S, Biccari A, Crotti S, Sensi F, Marangio A Exp Hematol Oncol. 2024; 13(1):61.

PMID: 38890716 PMC: 11184788. DOI: 10.1186/s40164-024-00526-2.


Biophysical interplay between extracellular matrix remodeling and hypoxia signaling in regulating cancer metastasis.

Lee S, Cho G, Kim D, Kim D Front Cell Dev Biol. 2024; 12:1335636.

PMID: 38544822 PMC: 10965814. DOI: 10.3389/fcell.2024.1335636.


References
1.
Gioiella F, Urciuolo F, Imparato G, Brancato V, Netti P . An Engineered Breast Cancer Model on a Chip to Replicate ECM-Activation In Vitro during Tumor Progression. Adv Healthc Mater. 2016; 5(23):3074-3084. DOI: 10.1002/adhm.201600772. View

2.
Lamhamedi-Cherradi S, Santoro M, Ramammoorthy V, Menegaz B, Bartholomeusz G, Iles L . 3D tissue-engineered model of Ewing's sarcoma. Adv Drug Deliv Rev. 2014; 79-80:155-71. PMC: 4397982. DOI: 10.1016/j.addr.2014.07.012. View

3.
Dvorak H, Weaver V, Tlsty T, Bergers G . Tumor microenvironment and progression. J Surg Oncol. 2011; 103(6):468-74. PMC: 3277953. DOI: 10.1002/jso.21709. View

4.
Fischbach C, Chen R, Matsumoto T, Schmelzle T, Brugge J, Polverini P . Engineering tumors with 3D scaffolds. Nat Methods. 2007; 4(10):855-60. DOI: 10.1038/nmeth1085. View

5.
Semenza G . The hypoxic tumor microenvironment: A driving force for breast cancer progression. Biochim Biophys Acta. 2015; 1863(3):382-391. PMC: 4678039. DOI: 10.1016/j.bbamcr.2015.05.036. View